GCP
BFRI icon

GSA Capital Partners’s Biofrontera BFRI Stock Holding History

GSA Capital Partners’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Buy
+10,022
New +$9.91K ﹤0.01% 1691

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

GSA Capital Partners's BFRI Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Biofrontera (BFRI) in Q2 2026: 10,022 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #1691 among its holdings.

19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

  • GSA Capital Partners held 10,022 shares of Biofrontera worth $9K as of Q2 2026.
  • Biofrontera was a new GSA Capital Partners position in Q2 2026.
  • Biofrontera made up ﹤0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1691 holding.
  • 19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.